title: [APPLICATION OF PREPARATION OF COCARNIT FOR PATIENTS AFTER ENDOPROSTHESIS OF HIP AND KNEE JOINTS].
abstract: In the article the results of clinical researches of efficiency of preparation of Cocarnit are resulted for patients after endoprosthesis of large joints. It is routine that for patients, receiving preparation of Cocarnit after the operation period there was a decline in the amount of complaints of patients on the total somatical state. Preparation of Ccocarnit was positively estimated outside patients, meaningful by-reactions, serving reason of abolition of preparation, was not marked. At the reception preparation of Cocarnit greater part of investigational laboratory indexes (table of contents of glucose, β-lipoproteines, total chondroitisulfates, TBC-productes (malonic dyaldehyde), activity of aspartataminotransferase, alkaline phosphatase and β-glutamyltranspeptidase), the indexes of clinical blood test and leucocytar indexes during a supervision did not have reliable differences from such as the persons of the control group, that confirms good bearab leness of the indicated preparation. Application preparation of Cocarnit for patients in composition the chart of treatment of patients after endoprosthesis of large joints brought maintenance over of cholesterol to the decline, glycoproteins, TBC-products (malonic dyaldehyde), activity of alaninaminotransferase, that specifies on normalizing influence of the indicated preparation in relation to the basic types of exchange of matters.
authors.forename: N A
authors.initials: NA
authors.lastname: Korzh
authors.forename: V A
authors.initials: VA
authors.lastname: Filippenko
authors.forename: F S
authors.initials: FS
authors.lastname: Leont'eva
authors.forename: V A
authors.initials: VA
authors.lastname: Tulyakov
authors.forename: S E
authors.initials: SE
authors.lastname: Bondarenko
mesh_terms: D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D019644:Arthroplasty, Replacement, Hip / Q000534:rehabilitation*; D019645:Arthroplasty, Replacement, Knee / Q000534:rehabilitation*; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002809:Chondroitin Sulfates / Q000097:blood; D004338:Drug Combinations; D005260:Female; D006621:Hip Joint / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D006801:Humans; D007719:Knee Joint / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects; D017060:Patient Satisfaction; D020011:Protective Agents / Q000627:therapeutic use*; D011788:Quality of Life; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use; D005723:gamma-Glutamyltransferase / Q000097:blood
chemical_list: D001786:Blood Glucose; D004338:Drug Combinations; D008077:Lipoproteins, LDL; D020011:Protective Agents; D009536:Niacinamide; D008315:Malondialdehyde; D000255:Adenosine Triphosphate; D002809:Chondroitin Sulfates; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D014805:Vitamin B 12; D013835:Thiamine Pyrophosphate